Dolby Laboratories, Inc. Deferred Revenue Recognized
Dolby Laboratories, Inc. (DLB) reported Deferred Revenue Recognized of $5.20 million for the 3-month period ending 2026-06-26, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-07-30
- Dolby Laboratories, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-06-26 was $5.20M, a 7.14% decline year-over-year.
- Dolby Laboratories, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-03-27 was $7.50M, a 0.00% change year-over-year.
- Dolby Laboratories, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-12-26 was $14.20M, a 5.19% increase year-over-year.
- Dolby Laboratories, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-06-27 was $5.60M, a 3.45% decline year-over-year.
- Dolby Laboratories, Inc. contract with customer, liability, revenue recognized for fiscal 2025 was $31.20M, a 1.96% increase from fiscal 2024.
- Dolby Laboratories, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $30.60M, a 67.21% increase from fiscal 2023.
- Dolby Laboratories, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $18.30M, a 8.93% increase from fiscal 2022.
- Dolby Laboratories, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $16.80M, a 20.00% increase from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-26 | $5.20M 10-Q · filed 2026-07-30 | $26.90M 10-Q · filed 2026-07-30 | ||
| 2026-03-27 | $7.50M 10-Q · filed 2026-04-30 | $21.70M 10-Q · filed 2026-04-30 | ||
| 2025-12-26 | $14.20M 10-Q · filed 2026-01-29 | |||
| 2025-09-26 | $31.20M 10-K · filed 2025-11-18 | |||
| 2025-06-27 | $5.60M 10-Q · filed 2025-07-31 | $26.60M 10-Q · filed 2025-07-31 | ||
| 2025-03-28 | $7.50M 10-Q · filed 2025-05-01 | |||
| 2024-12-27 | $13.50M 10-Q · filed 2025-01-30 | |||
| 2024-09-27 | $30.60M 10-K · filed 2024-11-19 | |||
| 2024-06-28 | $5.80M 10-Q · filed 2024-08-07 | $25.30M 10-Q · filed 2024-08-07 | ||
| 2024-03-29 | $7.30M 10-Q · filed 2024-05-02 | $19.50M 10-Q · filed 2024-05-02 | ||
| 2023-12-29 | $12.20M 10-Q · filed 2024-02-02 | |||
| 2023-09-29 | $18.30M 10-K · filed 2023-11-17 | |||
| 2023-06-30 | $3.10M 10-Q · filed 2023-08-03 | $14.70M 10-Q · filed 2023-08-03 | ||
| 2023-03-31 | $4.60M 10-Q · filed 2023-05-05 | $11.60M 10-Q · filed 2023-05-05 | ||
| 2022-12-30 | $7.00M 10-Q · filed 2023-02-02 | |||
| 2022-09-30 | $16.80M 10-K · filed 2022-11-18 | |||
| 2022-07-01 | $2.10M 10-Q · filed 2022-08-09 | $14.20M 10-Q · filed 2022-08-09 | ||
| 2022-04-01 | $5.00M 10-Q · filed 2022-05-05 | $12.10M 10-Q · filed 2022-05-05 | ||
| 2021-12-31 | $7.10M 10-Q · filed 2022-02-04 | |||
| 2021-09-24 | $14.00M 10-K · filed 2021-11-17 | |||
| 2021-06-25 | $3.10M 10-Q · filed 2021-07-29 | $11.40M 10-Q · filed 2021-07-29 | ||
| 2021-03-26 | $7.30M 10-Q · filed 2021-05-04 | |||
| 2020-12-25 | $4.50M 10-Q · filed 2021-01-29 | |||
| 2020-09-25 | $17.70M 10-K · filed 2020-11-16 | |||
| 2020-06-26 | $6.50M 10-Q · filed 2020-08-03 | |||
| 2020-03-27 | $6.30M 10-Q · filed 2020-05-04 | |||
| 2019-12-27 | $6.80M 10-Q · filed 2020-01-29 | |||
| 2019-09-27 | $6.60M 10-K · filed 2019-11-25 | |||
| 2019-06-28 | $6.60M 10-Q · filed 2019-08-02 |